文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

创伤后治疗使早期战术航空医疗后送对TBI后大脑可行

Postinjury treatments to make early tactical aeromedical evacuation practical for the brain after TBI.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论小鼠TBI模型中,模拟飞行前给予普萘洛尔、阿米替林或别嘌醇可改善生理指标、炎症和功能结局,别嘌醇可能最利于短期功能,普萘洛尔可能针对长期效应。

本研究在小鼠TBI模型中评估别嘌醇、普萘洛尔、腺苷/利多卡因/镁(ALM)或阿米替林在模拟航空医疗后送(AE)前给药的作用。所有治疗改善氧饱和度;普萘洛尔、阿米替林和别嘌醇改善AE诱发的心动过速;普萘洛尔和阿米替林降低24小时TNF-α;普萘洛尔、阿米替林和ALM降低7天血清MCP-1;阿米替林和别嘌醇改善AE小鼠Rotarod时间,仅别嘌醇改善常氧常压小鼠;普萘洛尔在两种条件下均减少p-tau,ALM仅在低氧低气压条件下减少。作者认为别嘌醇可能是预防短期功能缺陷的最佳选择,而普萘洛尔可能针对长期效应。

要点

  • 小鼠TBI后模拟AE前给药:普萘洛尔、阿米替林、别嘌醇均改善AE诱发的心动过速,所有治疗改善氧饱和度。
  • 24小时TNF-α:普萘洛尔和阿米替林降低TNF-α,别嘌醇和ALM仅在常氧常压小鼠中降低TNF-α。
  • 7天血清MCP-1:普萘洛尔、阿米替林和ALM降低血清MCP-1。
  • 30天p-tau:普萘洛尔在低氧低气压和常氧常压条件下均减少p-tau积累,ALM仅在低氧低气压条件下减少。
  • Rotarod:阿米替林和别嘌醇改善AE小鼠Rotarod时间,仅别嘌醇改善常氧常压小鼠Rotarod时间。

适用人群与场景

  • 小鼠接受TBI后,在模拟AE或常氧常压对照前给药。

处置流程与药物剂量

  • 小鼠TBI后、模拟AE前给予别嘌醇、普萘洛尔、阿米替林或ALM(腺苷/利多卡因/镁)。

研究设计与关键结果

  • 研究类型:基础科学文章;小鼠TBI模型,给予别嘌醇、普萘洛尔、阿米替林或ALM后模拟AE或常氧常压对照;监测心率、呼吸频率和氧饱和度;24小时、7天或30天处死;ELISA检测血清和脑细胞因子;Rotarod检测运动功能;免疫组化检测30天海马p-tau积累。
  • 所有治疗改善氧饱和度;普萘洛尔、阿米替林和别嘌醇改善AE诱发的心动过速。
  • 24小时:普萘洛尔和阿米替林降低TNF-α水平;别嘌醇和ALM仅在常氧常压小鼠中降低TNF-α水平。
  • 7天:普萘洛尔、阿米替林和ALM降低血清MCP-1。
  • Rotarod:阿米替林和别嘌醇改善AE小鼠Rotarod时间;仅别嘌醇改善常氧常压小鼠Rotarod时间。
  • p-tau:普萘洛尔在低氧低气压和常氧常压条件下均减少p-tau积累;ALM仅在低氧低气压条件下减少p-tau。

证据类型、等级与局限

  • 证据类型:基础科学文章(小鼠实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,别嘌醇可能是四种治疗中预防短期功能缺陷的最佳选择,而普萘洛尔可能针对长期效应。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) is common in civilians and military personnel. No potential therapeutics have been evaluated to prevent secondary injury induced by the hypobaric hypoxia (HH) environment integral to postinjury aeromedical evacuation (AE). We examined the role of allopurinol, propranolol, adenosine/lidocaine/magnesium (ALM), or amitriptyline administration prior to simulated flight following murine TBI.

METHODS: Mice underwent TBI and were given allopurinol, propranolol, amitriptyline, or ALM prior to simulated AE or normobaric normoxia (NN) control. Heart rate (HR), respiratory rate, and oxygen saturation (Spo2) were recorded throughout simulated AE. Mice were sacrificed at 24 hours, 7 days, or 30 days. Serum and cerebral cytokines were assessed by enzyme-linked immunosorbent assay. Motor function testing was performed with Rotarod ambulation. Immunohistochemistry was conducted to examine phosphorylated tau (p-tau) accumulation in the hippocampus at 30 days.

RESULTS: While all treatments improved oxygen saturation, propranolol, amitriptyline, and allopurinol improved AE-induced tachycardia. At 24 hours, both propranolol and amitriptyline reduced tumor necrosis factor alpha levels while allopurinol and ALM reduced tumor necrosis factor alpha levels only in NN mice. Propranolol, amitriptyline, and ALM demonstrated lower serum monocyte chemoattractant protein-1 7 days after AE. Both amitriptyline and allopurinol improved Rotarod times for AE mice while only allopurinol improved Rotarod times for NN mice. Propranolol was able to reduce p-tau accumulation under both HH and NN conditions while ALM only reduced p-tau in hypobaric hypoxic conditions.

CONCLUSION: Propranolol lowered post-TBI HR with reduced proinflammatory effects, including p-tau reduction. Amitriptyline-induced lower post-TBI HR and improved functional outcomes without affecting inflammatory response. Allopurinol did not affect vital signs but improved late post-TBI systemic inflammation and functional outcomes. Adenosine/lidocaine/magnesium provided no short-term improvements but reduced p-tau accumulation at 30 days in the HH cohort. Allopurinol may be the best of the four treatments to help prevent short-term functional deficits while propranolol may address long-term effects.

LEVEL OF EVIDENCE: Basic science article.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Singer KE, Wallen TE, Morris MC, et al. Postinjury treatments to make early tactical aeromedical evacuation practical for the brain after TBI. J Trauma Acute Care Surg. 2021. PMID: 33938511. doi:10.1097/TA.0000000000003259

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。